Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 889-892, February 1, 2008. doi: 10.1158/0008-5472.CAN-07-3095
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segal, N. H.
Right arrow Articles by Allison, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segal, N. H.
Right arrow Articles by Allison, J. P.

Immunology

Epitope Landscape in Breast and Colorectal Cancer

Neil H. Segal1,2, D. Williams Parsons4, Karl S. Peggs2,3, Victor Velculescu4, Ken W. Kinzler4, Bert Vogelstein4 and James P. Allison2,3

1 Department of Medicine, 2 Ludwig Center for Cancer Immunotherapy, and 3 Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, New York; and 4 Ludwig Center for Cancer Genetics and Therapeutics at The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland

Requests for reprints: James P. Allison, Ludwig Center of Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, 415 East 68th Street, Z-1560, New York, NY 10065. E-mail: allisonj{at}mskcc.org.

Key Words: genomic instability • tumor antigens • HLA

The finding that individual cancers contain many mutant genes not present in normal tissues has prompted considerable interest in the cancer epitope landscape. To further understand such effects, we applied in silico–based epitope prediction algorithms and high throughput post hoc analysis to identify candidate tumor antigens. Analysis of 1,152 peptides containing missense mutations previously identified in breast and colorectal cancer revealed that individual cancers accumulate on average ~10 and ~7 novel and unique HLA-A*0201 epitopes, respectively, including genes implicated in the neoplastic process. These data suggest that, with appropriate manipulation of the immune system, tumor cell destruction in situ may provide a polyvalent tumor vaccine without a requirement for knowledge of the targeted antigens. [Cancer Res 2008;68(3):889–92]




This article has been cited by other articles:


Home page
CarcinogenesisHome page
V. E. Velculescu
Defining the blueprint of the cancer genome
Carcinogenesis, June 1, 2008; 29(6): 1087 - 1091.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.